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Abstract 
 
Background: There is uncertainty about the relevance of animal foods to the etiology of 
ischemic heart disease (IHD). We examined meat, fish, dairy products and eggs and risk for IHD 
in the pan-European EPIC cohort. 
Methods: A prospective study of 409,885 men and women in nine European countries. Diet was 
assessed using validated questionnaires, calibrated using 24-hour recalls. Lipids and blood 
pressure were measured in a subsample. During 12.6 years mean follow up, 7198 participants 
had a myocardial infarction or died from IHD. The relationships of animal foods with risk were 
examined using Cox regression with adjustment for other animal foods and relevant covariates. 
Results: The hazard ratio (HR) for IHD was 1.19 (95% CI 1.06-1.33) for a 100 g/d increment in 
intake of red and processed meat, and this remained significant after excluding the first 4 years 
of follow-up (HR 1.25 [1.09-1.42]). Risk was inversely associated with intakes of yogurt (HR 
0.93 [0.89-0.98] per 100 g/d increment), cheese (HR 0.92 [0.86-0.98] per 30 g/d increment) and 
eggs (HR 0.93 [0.88-0.99] per 20 g/d increment); the associations with yogurt and eggs were 
attenuated and non-significant after excluding the first 4 years of follow-up. Risk was not 
significantly associated with intakes of poultry, fish or milk. In analyses modelling dietary 
substitutions, replacement of 100 kcal/d from red and processed meat with 100 kcal/d from fatty 
fish, yogurt, cheese or eggs was associated with approximately 20% lower risk of IHD. 
Consumption of red and processed meat was positively associated with serum non-HDL 
cholesterol concentration and systolic blood pressure, and consumption of cheese was inversely 
associated with serum non-HDL cholesterol. 
Conclusions: Risk for IHD was positively associated with consumption of red and processed 
meat, and inversely associated with consumption of yogurt, cheese and eggs, although the 
associations with yogurt and eggs may be influenced by reverse causation bias. It is not clear 
whether the associations with red and processed meat and cheese reflect causality, but they were 
consistent with the associations of these foods with plasma non-HDL cholesterol, and for red and 
processed meat with systolic blood pressure, which could mediate such effects. 
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Clinical Perspective 
 
What is new? 
• We followed the health of 400,000 men and women in nine European countries for 12 
years to examine the relevance of intake of animal foods to the etiology of ischemic 
heart disease. 
• Higher consumption of red and processed meat was positively associated with the risk 
for ischemic heart disease. 
• None of the other animal foods examined were positively associated with risk; intakes 
of fatty fish, yogurt, cheese and eggs were modestly inversely associated with risk. 
 
What are the clinical implications? 
• Higher intake of red and processed meat may increase risk of ischemic heart disease. 
• Substituting other foods for red and processed meat may reduce risk of ischemic heart 
disease 
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Introduction 
Ischemic heart disease (IHD) is the commonest disease and cause of death in Europe.1 The risk 
of IHD is affected by diet, but there is uncertainty about the relevance of intake of animal foods 
such as red and processed meat, poultry, fish, dairy products and eggs. Meat and dairy products 
are major dietary sources of saturated fatty acids; in the UK, for example, meat and meat 
products contribute 24% of saturated fat intake in adults, and milk and milk products contribute 
22%.2 Controlled feeding trials have shown that high intakes of saturated fatty acids raise 
circulating low density lipoprotein (LDL) cholesterol, an established risk factor for IHD, 
suggesting that higher intakes of foods rich in saturated fatty acids may increase the risk of IHD.3 
4 Meta-analyses of previous prospective studies of meat and incidence of fatal IHD have 
suggested that intake of processed meat may be associated with higher risk, whereas unprocessed 
red meat might not.5 6 For dairy products and eggs, systematic reviews of prospective studies 
have reported no consistent evidence that higher intakes are associated with a higher risk of 
IHD.7 8 Fatty fish consumption might reduce the risk of IHD because it is a rich source of long-
chain n-3 fatty acids, and a meta-analysis has suggested an inverse association between overall 
fish consumption and mortality from IHD.9  
 Here we report the relationships of these foods with risk of IHD in the European 
Prospective Investigation into Cancer and Nutrition (EPIC), a cohort of half a million men and 
women.10 11 To assess whether associations might be due to reverse causation, we examined the 
results after excluding the first four years of follow-up. To assess whether associations might be 
explained by known metabolic risk factors for IHD, we examined the cross-sectional 
associations of food intake with cholesterol fractions and blood pressure in a sub-sample of 
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participants, interpreting the relationships of foods with risk with respect to their associations 
with non-high density lipoprotein (HDL) cholesterol and systolic blood pressure. 
 
Methods  
Because of the sensitive nature of the data collected for this study, requests to access the dataset 
from qualified researchers trained in human subject confidentiality protocols may be sent to the 
International Agency for Research on cancer at http://epic.iarc.fr/access/index.php. 
Study population 
EPIC is a prospective study of approximately 520,000 men and women recruited through 23 
centres in 10 European countries, mostly between 1992 and 2000.10, 11 Participants in EPIC 
completed dietary and lifestyle questionnaires, and the majority also provided blood samples and 
had their blood pressure measured. The baseline data were centralized at the World Health 
Organization’s International Agency for Research on Cancer (IARC) in Lyon, France. All 
participants gave written informed consent and the study protocol was approved by the ethical 
review boards of IARC and the institutions where participants were recruited.10  
 Dietary intake during the year before enrolment was measured by country-specific diet 
assessment methods, in most centres food frequency questionnaires; these were validated using a 
standardized, co-ordinated approach.10 Dietary intakes estimated using a standardized and 
computerized 24-hour recall method were also collected from an 8% random sample across all 
centres, approximately 1.4 years after recruitment; the sample was stratified by age and sex, with 
weighting according to predicted disease rates in these strata, and distributed equally by season 
and day of the week.12 Details of the categorization of foods are in the Supplementary material.  
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 Assessments of the non-dietary variables were based on responses in the baseline 
questionnaires and categorized into the following groups: smoking (never, former, current <10 or 
unknown number of cigarettes per day, current 10-19 cigarettes per day, current ≥20 cigarettes 
per day, or unknown (2.4% of the cohort)), alcohol intake (not current drinker, sex-specific fifths 
of current intake: cut-points in men were 3.5, 9.7, 18.8 and 36.2 g/d, cut-points in women were 
0.9, 2.8, 6.9 and 13.9 g/d), physical activity (Cambridge physical activity index, based on 
occupational physical activity and cycling/other physical exercise, and categorised in 
approximate quartiles termed inactive, moderately inactive, moderately active, active, and 
unknown (2.2%))13, highest education level obtained (none or primary school only, secondary 
school, vocational qualification or university degree, unknown (4.3%)), employment status 
(currently employed or student, neither, unknown (11.4%)), histories of diabetes mellitus, 
hypertension and hyperlipidaemia (each self-reported: yes, no, unknown (4.2%, 5.5% and 23.7% 
respectively)). Body mass index (BMI: <22.5, 22.5-24.9, 25.0-27.4, 27.5-29.9, ≥30.0 kg/m2 and 
unknown (0.9%)) was calculated from measured height and weight (except for participants in 
Norway, and some participants in France and the UK, where height and weight were self-
reported). Baseline systolic and diastolic blood pressures were measured in millimetres of 
mercury by trained personnel (further details in Supplementary material online).14   
 Lipids were measured in stored plasma samples as part of the EPIC-CVD case-cohort 
study, which is nested within EPIC.11 The sub-cohort was randomly selected from participants 
with a stored blood sample, with selection stratified by the 23 EPIC recruitment centres. Details 
of methods are in the Supplementary material.  
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Ascertainment and verification of cases of ischemic heart disease 
The outcome was IHD, defined as the composite of first non-fatal myocardial infarction (MI: 
ICD-10 I21) or death from IHD (ICD-10 I20-25). Incident non-fatal MIs were ascertained in 
each EPIC centre using a combination of record linkage to morbidity or hospital registries, and 
self-reports followed by confirmation with medical records.11 Information on vital status was 
collected from mortality registries at the regional or national level in most centres except in 
Greece where vital status was ascertained by active follow-up of study participants and next of 
kin. Centres in Denmark, Greece, Italy, Norway and Spain validated all suspected cases of MI, 
whereas centres in France, the Netherlands, Sweden and the UK validated a subset of the 
suspected cases to assess the accuracy of the overall ascertainment process. A range of methods 
was used to confirm the diagnosis of IHD and included retrieving and assessing medical records 
or hospital discharge notes, contact with medical professionals, retrieval and assessment of death 
certificates, or verbal autopsy with the next of kin. The last year of follow-up varied across 
centres between 2003 and 2010, but was mainly 2008 or 2009. 
Statistical analysis 
Of the 518,502 participants for whom data were available, those with no dietary data, no non-
dietary (lifestyle) data, or those in the top or bottom 1% of the ratio of energy intake to energy 
requirement, were excluded (n=16,837), as were those who had a self-reported or unknown 
history of MI or stroke at baseline (n=11,308), 23 cases whose date of diagnosis was after the 
end of follow-up for each centre, and 23 participants with no follow-up data. These exclusions 
left a total of 490,311 participants, and further restricting the dataset to EPIC centres with known 
values for all of the animal foods (which meant excluding Heidelberg, Potsdam, Naples and 
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Umeå) left a total of 409,885 participants, including 7198 incident cases of non-fatal MI 
(n=5392) or fatal IHD (n=1806). 
 Follow-up was measured from recruitment until the date of first non-fatal MI or fatal IHD 
event, or censoring at the date of death from other causes, non-fatal non-MI IHD, the date at 
which follow-up for IHD events was considered complete, or emigration or other loss to follow-
up (1.3%). Relative risks as hazard ratios (HRs) and their 95% confidence intervals (95% CIs) 
were estimated using Cox regression models. All analyses were stratified by sex and EPIC centre 
and adjusted for exact age at recruitment (continuous), smoking, self-reported histories of 
diabetes, hypertension, and hyperlipidemia, physical activity, employment status, level of 
education, BMI (these latter eight covariates were all categorical variables, with ‘unknown’ 
categories added), current alcohol consumption (categorical), and intakes of energy, fruit and 
vegetables, dietary fibre from cereals, and percent energy from sugars (each continuous). In the 
main analyses of calibrated food intakes, the results for each animal source food were also 
adjusted simultaneously for the other animal source foods. 
 Participants were divided into fifths of self-reported intake for each animal food based on 
the recruitment questionnaire (for any foods with more than 20% zero values the categories were 
approximate fifths), with the quintiles calculated for all included participants, and a trend test 
performed by scoring the categorical fifths of intake 1 to 5 and treating this as a continuous 
variable. To test for whether the data were compatible with a linear trend, we also fitted models 
with the fifths of intake treated as a categorical variable; there were no significant improvements 
in fit when comparing the categorical intake model with the continuous (trend test) intake model, 
suggesting that any associations between food intake and risk were approximately linear. Then, 
to improve the comparability of dietary data across participating centres and to correct for 
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measurement error in relative risk estimates, the dietary data from the subset of participants with 
24-hour recalls were used to provide statistically calibrated estimates of dietary intakes for all 
included participants. HRs were calculated for increments in observed and calibrated intake of 
each food. Observed food intakes were calibrated using a fixed-effect linear model in which 
centre and sex specific 24-hour recall data from an 8% random sample of the cohort were 
regressed on the observed intakes, generating a calibrated intake corresponding to each observed 
intake.12 15 The sizes of the increments were chosen to approximate the difference in mean 24 
hour recall intake between participants in the lowest and highest fifths of observed intake, and 
with reference to the increments used in previous publications such the World Health 
Organization’s review of the carcinogenicity of red and processed meat.16 
 Using the results from the mutually-adjusted risks model, the effects of substituting 100 
kcal/d of each other animal food for 100 kcal/day of red and processed meat were estimated from 
the ratios of the risk (as measured by the hazard ratio) for each food in turn and the risk for red 
and processed meat.17  For example, if P and R represent the hazard ratios per 100 kcal/day 
yogurt and per 100 kcal/day red and processed meat in the mutually-adjusted risks model, the 
effect of substituting 100 kcal/day yogurt for 100 kcal/day red and processed meat is estimated 
by the ratio P/R; the difference in covariance was used to estimate the 95% confidence interval. 
 To examine whether the overall results might be influenced by reverse causality, we 
repeated the analyses after excluding the first 4 years of follow-up (i.e. with follow-up for all 
participants commencing 4 years after the date of recruitment). To examine whether associations 
between the animal foods and IHD risk were consistent across sub-groups of other risk factors, 
we also conducted separate analyses for subsets of sex, smoking status (never, former and 
current), prior disease status (participants with or without a history of diabetes, hypertension or 
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hyperlipidemia), age at recruitment (<55, 55-64, ≥65 years), BMI (<25.0, 25.0-29.9, ≥30.0 
kg/m2), European region (Northern Europe: Denmark, Norway, Sweden; Central Europe: France 
excepting Provence and SW France, Netherlands, UK; Southern Europe: Greece, Italy, Spain, 
Provence, SW France), and countries with partial (France, Netherlands, Sweden, UK) or 
complete (Denmark, Greece, Italy, Norway, Spain) validation of cases. Tests for heterogeneity of 
trend between sub-groups were obtained by comparing the risk coefficients for each sub-group 
using inverse variance weighting, testing for statistical significance using a chi-square test on k-1 
degrees of freedom where k is the number of sub-groups. 
 To examine whether dietary risk factors might act through major established 
physiological IHD risk factors, we examined the associations of food intakes with non-HDL 
cholesterol and systolic blood pressure, calculating mean levels of these biomarkers in each 
category of animal food intake (using linear regression to estimate least-squares means), with 
adjustment for age, sex and EPIC centre. 
 All analyses were performed using Stata version 15.1 (Stata Corporation, College Station, 
TX, USA), and a P-value less than 0.05 was considered statistically significant. 
 
Results 
After a mean follow-up of 12.6 years there were 7198 incident cases of MI or death from IHD. 
Table 1 shows participant characteristics by sex for all cohort participants and also for incident 
cases. On average, cases were 6-10 years older than average for the cohort, with higher mean 
BMI and lower mean alcohol intake. Cases were more likely to smoke, be inactive, unemployed, 
diabetic, have elevated blood pressure or proatherogenic lipids, lower mean observed intakes of 
fruit and vegetables, and moderate differences in intakes of animal foods. 
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 Table 2 shows the HRs and 95% CIs for IHD in each fifth of observed intake of animal 
foods, relative to the bottom fifth of intake, and P values for tests of trend based on the observed 
intakes. HRs in the top fifth of intake compared with the bottom fifth of intake were 1.13 (1.02-
1.26) for red and processed meat combined, 1.10 (0.99-1.21) for red meat and 1.10 (0.99-1.22) 
for processed meat. Intakes of poultry, white fish, fatty fish, milk and eggs were not associated 
with IHD, whereas intakes of yogurt and cheese were inversely associated with risk, with HRs 
(95% CIs) in the top fifths of 0.90 (0.84-0.97) and 0.88 (0.80-0.96)  
 Figure 1 shows the associations of IHD risk with statistically calibrated increments in 
intake of eight mutually-exclusive animal foods (including red and processed meat combined, 
but not red meat and processed meat separately), with mutual adjustment of risks for the animal 
foods (see online Supplemental Table 1 for HRs for uncalibrated and calibrated increments, 
without mutual adjustment). For red and processed meat combined, the HR (95% CI) was 1.19 
(1.06-1.33) for a 100 g/day increment in calibrated intake. The HRs for calibrated intakes of 
yogurt (100 g/d), cheese (30 g/d) and eggs (20 g/d) were 0.93 (0.89-0.98), 0.92 (0.86-0.98) and 
0.93 (0.88-0.99), respectively.  
 In analyses excluding the first 4 years of follow-up the association of risk with intake of 
red and processed meat was marginally stronger (HR per 100 g/day increment 1.25 (1.09-1.42), 
P=0.001), whereas the associations with calibrated intakes of yogurt and eggs were attenuated 
and neither these associations, nor the association with cheese, were statistically significant 
(Table 3). 
Substitution analyses 
Table 4 shows the HRs for modelled substitution of 100 kcal/day of calibrated intake of red and 
processed meat by 100 kcal/d of each of the other animal foods. Fatty fish, yogurt, cheese and 
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eggs were associated with significantly lower risks for IHD than red and processed meat (15% to 
24% reductions in risk per 100 kcal substituted per day). 
Sub-group analyses 
In analyses subdivided by history of diabetes, previous hypertension or hyperlipidemia, there 
was no appreciable heterogeneity in the associations of animal foods with IHD risk except for 
white fish, but this was not significantly associated with risk in either sub-group (see 
Supplementary material online, Supplemental Table 2). In analyses subdivided by smoking 
status, there was no appreciable heterogeneity in the associations of animal foods with IHD risk 
except for yogurt, which was inversely associated with risk in current smokers but not in never 
smokers or former smokers (Supplemental Table 3). In analyses subdivided by age, there was no 
appreciable heterogeneity in the associations of animal foods with IHD risk except for red and 
processed meat, which was strongly positively associated with risk in participants recruited 
before age 55, but not in older people (Supplemental Table 4). In analyses subdivided by sex, 
there was no appreciable heterogeneity in the associations of animal foods with IHD risk except 
for eggs, which were inversely associated with risk in men but not in women (Supplemental 
Table 5). There was no appreciable heterogeneity in the associations of animal foods with IHD 
risk subdivided by BMI or by European region (Supplemental Tables 6 and 7). There was 
evidence of heterogeneity by the extent of validation of cases in the associations of dietary intake 
with IHD risk for red and processed meat, and for milk (Supplemental Table 8); for red and 
processed meat, there was a large and highly significant association with risk in the countries 
with complete case verification, but not in the other countries. For milk there was a small 
positive association with risk in the countries with complete verification, but not in the other 
countries. 
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Associations of foods with plasma lipids and blood pressure 
Comparing participants in the highest fifth of intake of red and processed meat with those in the 
lowest fifth of such intake, non-HDL cholesterol was higher by 0.19 mmol/l (4.3%), and systolic 
blood pressure was higher by 3.3 mm Hg (2.5%); for processed meat, the difference in systolic 
blood pressure between these groups of participants was 3.7 mm Hg (2.8%). Comparing 
participants in the highest fifth of intake of cheese with those in the lowest fifth of such intake, 
non-HDL cholesterol was lower by 0.10 mmol/l, whereas the intake of cheese was unrelated to 
systolic blood pressure (see Supplemental Tables 9 and 10). 
 
Discussion 
In this large European cohort we observed a positive association between red and processed meat 
intake and risk of IHD, with a 19% (95% CI 6%-33%) higher risk per 100 g/day increment in 
calibrated intake. Red and processed meat showed separate (albeit borderline significant) 
associations with risk, which were each of similar magnitude. The association of risk with red 
and processed meat was observed after excluding the first 4 years of follow up and in 
participants without diabetes, or elevated blood pressure or proatherogenic lipids. These 
additional results, therefore, reduce the likelihood of reverse causation or residual confounding. 
By comparison, a previous meta-analysis of meat and risk of IHD reported that unprocessed red 
meat consumption was not associated with risk of IHD, whereas processed meat was, with a 42% 
higher risk per 50 g/d increment in intake.5 However, that previous review included only 769 
events from four studies for unprocessed red meat, including one case-control study; for 
processed meat it included 21,308 events from five studies, but most cases derived from one 
study for which the endpoint was total cardiovascular mortality rather than incident MI and fatal 
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IHD. A subsequent meta-analysis also concluded that processed meat but not unprocessed red 
meat was associated with IHD mortality, based on up to 1370 deaths from IHD.6 Hence, further 
work is needed to understand potential reasons for the differences with the current study’s 
results, which were based on over 7000 IHD events.  
 We observed no clear association of IHD risk with consumption of either white fish or 
fatty fish (although there was a borderline significant inverse association for fatty fish, and a 
significant inverse association for fatty fish in the substitution analyses; see below). The possible 
protective role of fish in IHD has been investigated for more than 30 years. A previous analysis 
of fish consumption and mortality in EPIC found no evidence that higher intakes of total, white 
or fatty fish were associated with mortality from IHD.18 By contrast, a meta-analysis of 4472 
deaths in 17 cohort studies suggested that there was an overall significant inverse association 
between fish intake and IHD mortality, but the association was not linear and the relative risk in 
the highest category of fish intake was not significantly lower than that in the lowest intake.9  
 Dairy products are a major source of dietary saturated fatty acids, but prospective 
observational studies have generally not shown a higher risk of IHD with a higher intake of 
foods such as milk, yogurt and cheese.19 20 We observed no association of milk with risk of IHD, 
which is consistent with a meta-analysis of 4391 incident IHD cases in six prospective studies.21 
We observed that yogurt consumption was inversely associated with risk of IHD. However, this 
association did not persist after exclusion of the initial 4 years of follow-up, and it showed 
heterogeneity by smoking status, with no association in never smokers (suggesting, therefore, 
that the observed association may partly be explained by changes in diet due to preclinical 
disease and/or residual confounding by smoking). Yogurt consumption is associated with healthy 
dietary patterns, behaviors and lifestyle factors22, yet a meta-analysis of 5 prospective studies 
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(number of cases unclear) reported no association between yogurt consumption and risk of 
IHD.23 We also observed that cheese consumption was inversely associated with risk of IHD; 
again, this inverse association was not significant after excluding the first four years of follow-
up, although the estimate was only slightly attenuated. A meta-analysis of 8 prospective studies 
with 7425 incident cases showed a lower risk for IHD in participants with a relatively high intake 
of cheese.24 It has been suggested that cheese has constituents which might act to reduce the risk 
of IHD, for example that the calcium in cheese forms insoluble soaps with fatty acids thus 
reducing absorption of saturated fatty acids, and that the calcium also binds to bile acids, 
reducing their enterohepatic circulation and possibly leading to a cholesterol lowering effect.19 25 
 Egg consumption was inversely associated with IHD risk overall, but this association was 
no longer evident after excluding the first 4 years of follow up, perhaps due to limited power, or 
because people with preclinical disease may have reduced their egg consumption. A recent meta-
analysis of six prospective studies including 5847 incident cases reported no association of egg 
consumption with risk of coronary heart disease.8 , whereas a recent large prospective study in 
China including 31,169 incident cases of IHD reported that egg intake was inversely associated 
with risk;26 it is possible that the risk associations found in the observational studies due to the a 
dietary pattern often accompanying high egg intake and/or the cluster of other risk factors in 
people with high egg consumption.27 
 The positive association we observed between red and processed meat and risk of IHD 
might be related to the saturated fat content of these foods. However, although dairy products are 
also relatively rich in saturated fats, intake of dairy products was not positively related to IHD 
risk in this study; in fact there was a suggestion of an inverse association between cheese intake 
and future risk of IHD. This finding might suggest that different food sources of saturated fat, 
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and/or different proportions of individual saturated fatty acids contained within meat and dairy 
foods, may differ in their impact on risk of IHD, which would affect the interpretation of 
previous studies of total dietary saturated fatty acids and risk.28 It is also possible that plant 
sources of protein may be associated with a lower risk of IHD than animal foods,29 and this 
should be considered in future analyses. 
Substitution of other animal foods for red and processed meat 
Our analyses showed that red and processed meat were positively associated with risk for IHD, 
whereas the other animal foods were not associated or inversely associated with risk. We 
therefore conducted analyses modelling isocaloric dietary substitutions, which showed that fatty 
fish, yogurt, cheese and eggs were associated with significantly lower risks for IHD when 
substituting for red and processed meat (15% to 24% lower risk per 100 kcal substituted per 
day). Plant foods might also be associated with a lower risk of cardiovascular disease than 
animal foods27 and may be considered in future analyses. 
Possible roles of plasma lipids and blood pressure 
The positive associations of  red and processed meat and the inverse association of cheese 
consumption with the risk of IHD might be explained through the associations of these foods 
with well-established risk factors for IHD, such as cholesterol fractions and systolic blood 
pressure. Compared to participants in the lowest fifth of intake of red and processed meat, those 
in the top fifth had a higher non-HDL cholesterol by 0.19 mmol/l and a higher systolic blood 
pressure by 3.3 mm Hg; the difference in systolic blood pressure was larger for processed meat 
than for red meat (3.7 and 2.2 mm Hg, respectively), consistent with previous observations and 
possibly due to the high salt content of most processed meats.30  
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 Based on results from the Emerging Risk Factors Collaboration and the Prospective 
Studies Collaboration31 32, these differences would be expected to be associated with higher IHD 
risks of 8% and 12%, respectively. Such modelling suggests that the observed (uncalibrated) 
13% higher risk in the top fifth of intake of red and processed meat could be readily explained by 
the differences in blood lipids and blood pressure. Other mechanisms might also be involved, for 
example, higher intakes of red and processed meat might increase the risk of IHD through the 
conversion of carnitine in meat into trimethylamine oxide.33 Compared to participants in the 
lowest fifth of intake of cheese, those in the top fifth had lower non-HDL cholesterol by 0.10 
mmol/l, but no significant difference in systolic blood pressure. Again on the basis of results 
from the Prospective Studies Collaboration, this difference in lipids would be expected to be 
associated with a 4% lower IHD risk, indicating that the observed 12% lower IHD risk in the top 
fifth of intake of cheese might be only partly explained by standard lipid fractions.  
Strengths and limitations 
Strengths of this study are the large number of cases, the prospective design, the wide range of 
diets across Europe, the calibration of the dietary data using 24-hour recalls, and the ability to 
adjust for major risk factors for IHD and to estimate the impacts of associations with circulating 
lipids and blood pressure.  
 As with all observational studies, a potential limitation is that the associations may be 
influenced by confounding by other risk factors. We have adjusted our results for major risk 
factors for IHD, including smoking and BMI as well as socio-economic factors. However, as the 
magnitudes of the associations we observed were relatively modest, we cannot discount that the 
results have been influenced by residual confounding by adiposity, socio-economic factors or 
other unmeasured factors. Another potential limitation is that, due to the multi-centre design of 
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the cohort, there were some variations in the ascertainment and validation of the endpoint; the 
positive association of red and processed meat with risk for IHD was strong in the countries with 
complete validation of cases. It is also possible that associations of specific foods with risk may 
vary between populations due to differences in associations with other aspects of diet.  
Conclusion 
This large prospective study in Europe shows a moderate positive association between 
consumption of red and processed meat and risk of IHD, and it suggests a modest inverse 
association between consumption of cheese and IHD risk. It is not clear whether these 
associations reflect causality, but they were consistent with the associations of these foods with 
plasma non-HDL cholesterol, and for red and processed meat with systolic blood pressure, which 
could mediate such effects. 
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Table 1. Participant characteristics at recruitment in 409,885 participants by gender and incident case status for 
first non-fatal MI or fatal IHD – EPIC Study 
 
Characteristic Men Women 
All men Male cases All women Female 
cases 
Number of participants 106751 4608 303134 2590 
Age, y (SD) 52.7 (10.3) 58.7 (8.3) 51.3 (9.8) 61.0 (8.5) 
BMI, kg/m2 (SD)* 26.6 (3.7) 27.3 (3.8) 25.0 (4.4) 27.0 (4.7) 
Alcohol in current drinkers, g/day (SD) 22.4 (23.2) 20.6 (22.4) 9.2 (12.0) 7.9 (11.4) 
Not current alcohol drinker, n (%) 5409 (5.1) 304 (6.6) 38716 (12.8) 395 (15.3) 
Smoking status and cigarettes/day, n (%)*     
 Never smoker 32986 (31.4) 926 (20.3) 168240 (57.0) 1071 (41.7) 
 Former smoker 38347 (36.5) 1661 (36.5) 68785 (23.3) 563 (21.9) 
 Current smoker, <10 or number 
unknown 
12198 (11.6) 621 (13.6) 16637 (5.6) 195 (7.6) 
 Current smoker, 10-19 8216 (7.8) 513 (11.3) 23900 (8.1) 436 (17.0) 
 Current smoker, ≥20 13281 (12.6) 835 (18.3) 17522 (5.9) 306 (11.9) 
Highest level of education completed, n (%)*     
 None or primary 37929 (36.8) 2129 (47.9) 85431 (29.5) 1242 (51.8) 
 Secondary 13854 (13.4) 444 (10.0) 75699 (26.2) 225 (9.4) 
 Vocational or university 51281 (49.8) 1868 (42.1) 128157 (44.3) 930 (38.8) 
Cambridge physical activity index, n (%)*     
 Inactive 20078 (19.4) 1188 (26.4) 65052 (21.9) 866 (34.1) 
 Moderately inactive 31545 (30.4) 1365 (30.4) 103286 (34.8) 855 (33.6) 
 Moderately active 25068 (24.2) 958 (21.3) 83872 (28.2) 458 (18.0) 
 Active 27034 (26.1) 985 (21.9) 44910 (15.1) 362 (14.2) 
Employed or student, n (%)*     
 Yes 68176 (75.0) 2338 (58.2) 176825 (64.9) 886 (37.1) 
 No 22727 (25.0) 1677 (41.8) 95471 (35.1) 1503 (62.9) 
History of diabetes, n (%)*     
 No 100468 (96.7) 4095 (93.0) 282565 (97.8) 2233 (91.6) 
 Yes 3379 (3.3) 308 (7.0) 6220 (2.2) 205 (8.4) 
Previous hypertension, n (%)*     
 No 83183 (82.5) 3160 (73.0) 238272 (83.2) 1591 (64.4) 
 Yes 17697 (17.5) 1171 (27.0) 48209 (16.8) 879 (35.6) 
Prior hyperlipidemia, n (%)*     
 No 67978 (81.3) 2082 (73.7) 200039 (87.2) 1230 (78.6) 
 Yes 15586 (18.7) 742 (26.3) 29309 (12.8) 335 (21.4) 
Region, n (%)&     
 Northern Europe 34924 (32.7) 2510 (54.5) 80922 (26.7) 1253 (48.4) 
 Central Europe 32300 (30.3) 1059 (23.0) 135150 (44.6) 936 (36.1) 
 Southern Europe 39527 (37.0) 1039 (22.5) 87062 (28.7) 401 (15.5) 
Energy intake, kcal/day (SD) 2460 (650) 2436 (636) 1949 (536) 1878 (505) 
Percent energy from sugars (SD) 17.3 (6.0) 17.7 (6.1) 19.4 (5.8) 20.5 (6.0) 
Cereal fibre, g/day (SD) 10.3 (5.7) 10.4 (6.0) 7.8 (4.4) 7.9 (4.6) 
Fruit and vegetables, g/day (SD) 455 (292) 387 (255) 484 (267) 423 (243) 
Foods, g/day, medians (lower and upper quartiles)     
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   Red and processed meat 92 (54, 132) 101 (66, 142) 61 (35, 91) 66 (42, 95) 
      Red meat (g/day) 58 (30, 87) 60 (33, 89) 34 (16, 59) 40 (21, 62) 
      Processed meat 27 (11, 49) 35 (18, 58) 20 (8, 36) 21 (10, 37) 
   Poultry meat 16 (8, 33) 16 (6, 31) 14 (5, 23) 13 (4, 24) 
   White fish 12 (3, 23) 14 (2, 25) 11 (2, 23) 10 (1, 20) 
   Fatty fish 8 (2, 16) 8 (1, 17) 8 (2, 16) 7 (1, 16) 
   Milk 171 (38, 321) 216 (55, 432) 148 (19, 294) 218 (70, 387) 
   Yogurt 13 (0, 55) 8 (0, 61) 36 (3, 97) 27 (2, 94) 
   Cheese 29 (15, 55) 25 (13, 51) 30 (16, 55) 23 (12, 42) 
   Eggs 16 (7, 27) 17 (8, 29) 15 (7, 24) 14 (7, 23) 
* Value or category unknown for some participants. 
& Northern Europe: Denmark, Norway, Sweden (Malmö); Central Europe: France excepting Provence and SW France, 
Netherlands, UK; Southern Europe: Greece, Italy, Spain, Provence, SW France. 
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Table 2. Hazard ratios* (95% confidence intervals) for first non-fatal MI or fatal IHD in 409,885 participants by 
overall fifths of observed (self-reported)  intake of selected animal foods, relative to the bottom fifth of intake – EPIC 
Study 
 
Food No. of cases Fifth of intake& P for trend# 
2 3 4 5 
Red and 
processed meat 
7198 1.03 (0.93-1.13) 1.05 (0.95-1.15) 1.06 (0.96-1.17) 1.13 (1.02-1.26) 0.014 
  Red meat 7198 0.98 (0.89-1.08) 1.05 (0.96-1.15) 1.06 (0.97-1.17) 1.10 (0.99-1.21) 0.016 
  Processed meat 7198 0.98 (0.89-1.09) 1.03 (0.93-1.14) 1.07 (0.97-1.18) 1.10 (0.99-1.22) 0.007 
Poultry meat 7198 1.00 (0.92-1.09) 0.99 (0.92-1.08) 1.00 (0.92-1.09) 1.01 (0.94-1.10) 0.77 
White fish 7198 0.98 (0.90-1.07) 1.00 (0.92-1.08) 0.96 (0.89-1.04) 1.02 (0.94-1.11) 0.93 
Fatty fish 7198 0.96 (0.88-1.03) 0.94 (0.88-1.02) 0.95 (0.88-1.03) 0.92 (0.86-0.99) 0.054 
Milk 7198 0.91 (0.83-1.00) 0.97 (0.89-1.06) 0.97 (0.89-1.06) 0.97 (0.88-1.06) 0.66 
Yogurt 7198 1.05 (0.97-1.14) 0.99 (0.92-1.07) 0.94 (0.87-1.02) 0.90 (0.84-0.97) 0.0004 
Cheese 7198 0.95 (0.88-1.01) 0.90 (0.83-0.97) 0.91 (0.84-0.98) 0.88 (0.80-0.96) 0.003 
Eggs 7198 0.96 (0.89-1.04) 0.97 (0.90-1.05) 1.02 (0.94-1.09) 0.93 (0.86-1.01) 0.37 
* Hazard ratios are adjusted for age (continuous), smoking status and number of cigarettes per day, history of diabetes, previous 
hypertension, prior hyperlipidemia, Cambridge physical activity index, employment status, level of education completed, BMI 
(all categorical, with ‘unknown’ categories added), current alcohol consumption (non-drinkers and sex-specific fifths of intake 
among drinkers), and observed intakes of energy, fruit and vegetables combined, sugars (as % energy) and fibre from cereals 
(each continuous), and stratified by sex and EPIC centre. 
& The median observed intakes (g/day) within each fifth of intake were as follows: red and processed meat – 12, 45, 67, 93, 138; 
red meat – 3, 22, 39, 60, 94; processed meat – 1, 11, 22, 35, 61; poultry meat – 0, 7, 15, 22, 46; white fish – 0, 4, 11, 20, 44; 
fatty fish – 0, 3, 8, 14, 29; milk – 0, 49, 150, 288, 470; yogurt – 0, 7, 27, 71, 150; cheese – 5, 18, 30, 50, 86; eggs – 4, 9, 15, 22, 
40; for any foods with more than 20% zero values the categories were approximate fifths. The mean 24-hour recall intakes 
(g/day) within each fifth of intake were as follows: red and processed meat – 37, 61, 75, 93, 126; red meat – 24, 33, 44, 54, 69; 
processed meat – 10, 25, 34, 43, 60; poultry meat – 11, 13, 17, 22, 27; white fish – 11, 7, 13, 17, 31; fatty fish – 8, 10, 12, 14, 
21; milk – 33, 79, 176, 240, 384; yogurt – 15, 14, 34, 67, 122; cheese – 15, 25, 33, 40, 54; eggs – 8, 12, 14, 18, 26. 
# Tests of trend were performed scoring the fifths of intake 1-5.   
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Table 3. Mutually-adjusted hazard ratios* (95% confidence intervals) for first non-fatal MI or 
fatal IHD in 406,908 participants per increment in calibrated intake of selected animal foods 
after excluding the first 4 years of follow-up – EPIC Study 
 
Food Increment 
(g/day) 
No. of cases HR (95% CI), 
mutually adjusted 
P for trend# 
Red and processed meat 100 5506 1.25 (1.09-1.42) 0.001 
Poultry meat 20 5506 0.99 (0.94-1.05) 0.84 
White fish 15 5506 1.02 (0.98-1.06) 0.39 
Fatty fish 15 5506 0.96 (0.91-1.00) 0.072 
Milk 200 5506 1.03 (0.99-1.07) 0.11 
Yogurt 100 5506 0.97 (0.92-1.03) 0.28 
Cheese 30 5506 0.93 (0.86-1.00) 0.055 
Eggs 20 5506 0.96 (0.90-1.03) 0.28 
* Hazard ratios are adjusted for age (continuous), smoking status and number of cigarettes per day, 
history of diabetes, previous hypertension, prior hyperlipidemia, Cambridge physical activity index, 
employment status, level of education completed, BMI (all categorical, with ‘unknown’ categories 
added), current alcohol consumption (non-drinkers and sex-specific fifths of intake among drinkers), and 
calibrated intakes of energy, fruit and vegetables combined, sugars (as % energy), fibre from cereals, and 
each other food (each continuous), and stratified by sex and EPIC centre. 
# Tests of trend were performed using the calibrated intake (continuous). 
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Table 4. Hazard ratios* (95% confidence intervals) for first non-fatal MI or fatal IHD for 
substitution of 100 kcal/day increment in calibrated energy intake from each food for 100 
kcal/day increment in calibrated energy intake from red and processed meat 
 
Food HR (95% CI), substituting 100 kcal/day of this food for 100 
kcal/day red and processed meat 
Poultry meat 0.89 (0.76-1.04) 
White fish 1.00 (0.78-1.26) 
Fatty fish 0.81 (0.69-0.95) 
Milk 0.95 (0.90-1.00) 
Yogurt 0.84 (0.76-0.92) 
Cheese 0.85 (0.79-0.92) 
Eggs 0.76 (0.62-0.92) 
* Hazard ratios are adjusted for age (continuous), smoking status and number of cigarettes per day, 
history of diabetes, previous hypertension, prior hyperlipidaemia, Cambridge physical activity index, 
employment status, level of education completed, BMI (all categorical, with ‘unknown’ categories 
added), current alcohol consumption (non-drinkers and sex-specific fifths of intake among drinkers), and 
calibrated intakes of energy, fruit and vegetables combined, sugars (as % energy) and fibre from cereals 
(each continuous), and each other food, as appropriate (each continuous), and stratified by sex and EPIC 
centre.  Results are based on 7198 cases among 409,885 participants with known values for all of the 
animal foods. 
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Figure Legend 
 
Figure 1. Mutually-adjusted hazard ratios (95% confidence intervals) for first non-fatal MI or 
fatal IHD per increment in statistically calibrated intake of animal foods 
Hazard ratios (HR) are adjusted for age (continuous), smoking status and number of cigarettes 
per day, history of diabetes, previous hypertension, prior hyperlipidemia, Cambridge physical 
activity index, employment status, level of education completed, BMI (all categorical, with 
‘unknown’ categories added), current alcohol consumption (non-drinkers and sex-specific fifths 
of intake among drinkers), and calibrated intakes of energy, fruit and vegetables combined, 
sugars (as % energy), fibre from cereals, and each other food (each continuous), and stratified in 
the analysis by sex and EPIC centre.  
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Mutually-adjusted hazard ratios (95% CI) for first non-fatal MI or fatal IHD
per increment in statistically calibrated intake of selected animal foods
Food
Increment
(g/day)
No. of
cases HR (95% CI) HR & 95% CI P for trend
Red and processed meat         100 7198 1.19 (1.06-1.33)    0.003
Poultry meat  20 7198 0.99 (0.94-1.04)    0.68 
White fish  15 7198 1.01 (0.97-1.04)    0.72 
Fatty fish  15 7198 0.96 (0.92-1.01)    0.091
Milk 200 7198 1.02 (0.99-1.06)    0.18 
Yogurt 100 7198 0.93 (0.89-0.98)    0.007
Cheese  30 7198 0.92 (0.86-0.98)    0.010
Eggs  20 7198 0.93 (0.88-0.99)    0.023
0.8 1.0 1.2 1.5
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